Literature DB >> 30768897

Chitosan Acetylation Degree Influences the Physical Properties of Polysaccharide Nanoparticles: Implication for the Innate Immune Cells Response.

Franco Furlani1, Pasquale Sacco1, Eva Decleva1, Renzo Menegazzi1, Ivan Donati1, Sergio Paoletti1, Eleonora Marsich2.   

Abstract

The aim of the present contribution is twofold as it reports (i) on the role played by chitosan acetylation degree for the stability of nanoparticles (NPs) formed with hyaluronan and (ii) on the effect of the interaction of such NPs with immune cells. Chitosans with similar viscosity-average molecular weight, [Formula: see text], (i.e., 200 000) and different fractions of acetylated units ( FA) together with low-molecular-weight hyaluronan were chosen for developing a select library of formulations via electrostatic complex coacervation. The resulting NPs were analyzed in terms of size, polydispersity, surface charge, and stability in physiological-mimicked media by dynamic light scattering. Only medium acetylated chitosan ( FA = 0.16) guaranteed the stability of NPs. To explore the effect of NPs interaction with immune cells, the release of proinflammatory cytokines and the reactive oxygen species production by human macrophages and neutrophils, respectively, were evaluated. Strikingly, a structure-function relationship emerged, showing that NPs made of chitosans with FA = 0.02, 0.25, 0.46, and 0.63 manifested a proinflammatory activity, linked to the instability of the system. Conversely, NPs made of chitosan with FA = 0.16 neither modified the functional response of macrophages nor that of neutrophils. Of note, such NPs were found to possess additional properties potentially advantageous in applications such as delivery of therapeutics to target inflamed sites: (i) they are devoid of cytotoxic effects, (ii) they avoid engulfment during the early stage of interaction with macrophages, and (iii) they are muco-adhesive, thereby providing for site-specificity and long-residence effects.

Entities:  

Keywords:  chitosan acetylation degree; inflammation; macrophages; nanoparticles; neutrophils; stability

Mesh:

Substances:

Year:  2019        PMID: 30768897     DOI: 10.1021/acsami.8b21791

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  6 in total

1.  Long lasting mucoadhesive membrane based on alginate and chitosan for intravaginal drug delivery.

Authors:  Fabio Tentor; Giorgia Siccardi; Pasquale Sacco; Danilo Demarchi; Eleonora Marsich; Kristoffer Almdal; Sanjukta Bose Goswami; Anja Boisen
Journal:  J Mater Sci Mater Med       Date:  2020-02-14       Impact factor: 3.896

2.  On the Formation and Stability of Chitosan/Hyaluronan-Based Complex Coacervates.

Authors:  Franco Furlani; Pietro Parisse; Pasquale Sacco
Journal:  Molecules       Date:  2020-02-27       Impact factor: 4.411

3.  Polysaccharide-Based Nanomaterials for Ocular Drug Delivery: A Perspective.

Authors:  Haozhe Yu; Wenyu Wu; Xiang Lin; Yun Feng
Journal:  Front Bioeng Biotechnol       Date:  2020-12-10

Review 4.  Ionotropic Gelation of Chitosan Flat Structures and Potential Applications.

Authors:  Pasquale Sacco; Seidy Pedroso-Santana; Yogesh Kumar; Nicolas Joly; Patrick Martin; Patrizia Bocchetta
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

Review 5.  Biomaterials for Regenerative Medicine in Italy: Brief State of the Art of the Principal Research Centers.

Authors:  Francesca Camponogara; Federica Zanotti; Martina Trentini; Elena Tiengo; Ilaria Zanolla; Elham Pishavar; Elisa Soliani; Marco Scatto; Paolo Gargiulo; Ylenia Zambito; Stefano De Luca; Letizia Ferroni; Barbara Zavan
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

6.  Controlled Liposome Delivery from Chitosan-Based Thermosensitive Hydrogel for Regenerative Medicine.

Authors:  Franco Furlani; Arianna Rossi; Maria Aurora Grimaudo; Giada Bassi; Elena Giusto; Filippo Molinari; Florigio Lista; Monica Montesi; Silvia Panseri
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.